The International Generic and Biosimilar medicines Association (IGBA) welcomes the Australian Government's decision to maintain the existing naming convention for biological, including biosimilar, medicines, that is to continue using the Australian biological name (without a specific identifier suffix) and to strengthen the adverse event reporting. This includes making the product's trade name, as well as the non-proprietary name, a mandatory field when reporting an adverse event to the Therapeutic Goods Administration (TGA).

With regard to the recent election of Ms María Elósegui Ichaso as judge of the European Court of Human Rights (ECHR) in respect of Spain, S&D Group vice-presidents Elena Valenciano and Tanja Fajon said:  
 

(25 January 2018, Opatija) Eurochild’s next bi-annual conference takes place in Opatija, Croatia from 29-31 October 2018. The conference entitled ‘Building a better Europe with children: All Aboard!’ will be hosted by Society ‘Our Children’ Opatija in partnership with the City of Opatija, under the auspices of the President of the Republic of Croatia Kolinda Grabar-Kitarovic.